146 related articles for article (PubMed ID: 1400473)
21. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans.
Ikewaki K; Zech LA; Kindt M; Brewer HB; Rader DJ
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):306-12. PubMed ID: 7749839
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.
Melchior GW; Castle CK; Murray RW; Blake WL; Dinh DM; Marotti KR
J Biol Chem; 1994 Mar; 269(11):8044-51. PubMed ID: 8132527
[TBL] [Abstract][Full Text] [Related]
23. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D
Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436
[TBL] [Abstract][Full Text] [Related]
24. Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet.
Escolà-Gil JC; Marzal-Casacuberta A; Julve-Gil J; Ishida BY; Ordóñez-Llanos J; Chan L; González-Sastre F; Blanco-Vaca F
J Lipid Res; 1998 Feb; 39(2):457-62. PubMed ID: 9580110
[TBL] [Abstract][Full Text] [Related]
25. Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II.
Broedl UC; Jin W; Fuki IV; Millar JS; Rader DJ
J Lipid Res; 2006 Oct; 47(10):2191-7. PubMed ID: 16877778
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-II.
Pastier D; Dugué S; Boisfer E; Atger V; Tran NQ; van Tol A; Chapman MJ; Chambaz J; Laplaud PM; Kalopissis AD
Biochemistry; 2001 Oct; 40(41):12243-53. PubMed ID: 11591143
[TBL] [Abstract][Full Text] [Related]
27. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance.
Castellani LW; Goto AM; Lusis AJ
Diabetes; 2001 Mar; 50(3):643-51. PubMed ID: 11246886
[TBL] [Abstract][Full Text] [Related]
28. A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins.
Deeb SS; Cheung MC; Peng RL; Wolf AC; Stern R; Albers JJ; Knopp RH
J Biol Chem; 1991 Jul; 266(21):13654-60. PubMed ID: 1906882
[TBL] [Abstract][Full Text] [Related]
29. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.
Rader DJ; Castro G; Zech LA; Fruchart JC; Brewer HB
J Lipid Res; 1991 Nov; 32(11):1849-59. PubMed ID: 1770304
[TBL] [Abstract][Full Text] [Related]
30. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice.
Reardon CA; Kan HY; Cabana V; Blachowicz L; Lukens JR; Wu Q; Liadaki K; Getz GS; Zannis VI
Biochemistry; 2001 Nov; 40(45):13670-80. PubMed ID: 11695916
[TBL] [Abstract][Full Text] [Related]
31. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.
Clay MA; Cehic DA; Pyle DH; Rye KA; Barter PJ
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287
[TBL] [Abstract][Full Text] [Related]
32. Selective uptake of HDL cholesteryl esters is active in transgenic mice expressing human apolipoprotein A-I.
Khoo JC; Pittman RC; Rubin EM
J Lipid Res; 1995 Mar; 36(3):593-600. PubMed ID: 7775870
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.
Rye KA; Wee K; Curtiss LK; Bonnet DJ; Barter PJ
J Biol Chem; 2003 Jun; 278(25):22530-6. PubMed ID: 12690114
[TBL] [Abstract][Full Text] [Related]
34. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I.
Batal R; Tremblay M; Krimbou L; Mamer O; Davignon J; Genest J; Cohn JS
Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):655-64. PubMed ID: 9555873
[TBL] [Abstract][Full Text] [Related]
35. Lipid transfer particle-induced transformation of human high density lipoprotein into apolipoprotein A-I-deficient low density particles.
Silver ET; Scraba DG; Ryan RO
J Biol Chem; 1990 Dec; 265(36):22487-92. PubMed ID: 2125050
[TBL] [Abstract][Full Text] [Related]
36. Mass spectrometric determination of apolipoprotein molecular stoichiometry in reconstituted high density lipoprotein particles.
Massey JB; Pownall HJ; Macha S; Morris J; Tubb MR; Silva RA
J Lipid Res; 2009 Jun; 50(6):1229-36. PubMed ID: 19179308
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.
Rosales C; Gillard BK; Courtney HS; Blanco-Vaca F; Pownall HJ
Biochemistry; 2009 Aug; 48(33):8070-6. PubMed ID: 19618959
[TBL] [Abstract][Full Text] [Related]
38. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma.
Kido T; Kurata H; Kondo K; Itakura H; Okazaki M; Urata T; Yokoyama S
Sci Rep; 2016 Aug; 6():31532. PubMed ID: 27526664
[TBL] [Abstract][Full Text] [Related]
40. Isolation and identification of HDL particles of low molecular weight.
Atmeh RF
J Lipid Res; 1990 Oct; 31(10):1771-80. PubMed ID: 2127794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
